Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
- Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.
- 10/31/2024
|
Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript
- Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024.
- 10/30/2024
|
Avanos Medical (AVNS) Q3 Earnings Meet Estimates
- Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago.
- 10/30/2024
|
Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO
- ALPHARETTA, Ga. , Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody.
- 10/30/2024
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
- ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m.
- 10/23/2024
|
Avanos Medical (AVNS) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 10/17/2024
|
Should Value Investors Buy Avanos Medical (AVNS) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/09/2024
|
Reasons to Add Avanos Medical Stock in Your Portfolio Now
- AVNS's strong product line and focus on R&D raise optimism about the stock.
- 10/03/2024
|
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/19/2024
|
Why Avanos Medical (AVNS) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/13/2024
|
Avanos Medical Stock May Gain From Brand Partnership With NFL
- AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa.
- 09/12/2024
|
Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference
- ALPHARETTA, Ga. , Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22nd Annual Best Ideas Conference 2024 on Mon.
- 09/09/2024
|
Is Avanos Medical (AVNS) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/22/2024
|
Should Value Investors Buy Avanos Medical (AVNS) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/05/2024
|
Avanos (AVNS) Q2 Earnings Top Estimates, Gross Margin Contracts
- Strength in Avanos' (AVNS) Digestive Health segment drives its second-quarter performance.
- 08/01/2024
|
Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Scott Galovan - SVP, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - SVP, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical Q2 2024 Earnings Call. At this time, all lines are in a listen-only mode.
- 07/31/2024
|
Avanos Medical (AVNS) Beats Q2 Earnings and Revenue Estimates
- Avanos Medical (AVNS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.24 per share a year ago.
- 07/31/2024
|
Avanos Medical, Inc. Announces Second Quarter 2024 Results
- ALPHARETTA, Ga. , July 31, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2024 financial results.
- 07/31/2024
|
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
- Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
- 07/26/2024
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
- ALPHARETTA, Ga. , July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2024 on Wednesday, July 31 at 9 a.m.
- 07/24/2024
|
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
- ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
- 07/01/2024
|
Natixis Advisors L.P. Makes New Investment in Avanos Medical, Inc. (NYSE:AVNS)
- Natixis Advisors L.P. bought a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 14,142 shares of the company’s stock, valued at approximately $317,000. A number of other hedge funds and other institutional investors also recently made changes to their positions in AVNS. William Blair Investment Management LLC purchased a new position in shares of Avanos Medical in the 3rd quarter valued at approximately $22,134,000. RGM Capital LLC lifted its position in Avanos Medical by 6.8% during the third quarter. RGM Capital LLC now owns 2,951,691 shares of the company’s stock valued at $59,683,000 after buying an additional 189,017 shares during the period. Foundry Partners LLC boosted its holdings in shares of Avanos Medical by 74.6% during the 4th quarter. Foundry Partners LLC now owns 371,029 shares of the company’s stock valued at $8,322,000 after buying an additional 158,473 shares in the last quarter. Kestrel Investment Management Corp purchased a new stake in shares of Avanos Medical in the 4th quarter worth about $3,265,000. Finally, Jupiter Asset Management Ltd. increased its stake in shares of Avanos Medical by 234.2% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 149,983 shares of the company’s stock worth $3,033,000 after acquiring an additional 105,100 shares in the last quarter. Institutional investors own 95.17% of the company’s stock. Wall Street Analysts Forecast Growth Several equities research analysts recently commented on the stock. JMP Securities reissued a “market perform” rating on shares of Avanos Medical in a research note on Tuesday, May 7th. StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 11th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Avanos Medical currently has an average rating of “Moderate Buy” and a consensus target price of $31.00. Read Our Latest Stock Report on Avanos Medical Insider Activity In related news, CFO Michael Greiner sold 8,000 shares of Avanos Medical stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $19.12, for a total transaction of $152,960.00. Following the transaction, the chief financial officer now directly owns 151,495 shares in the company, valued at $2,896,584.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.90% of the company’s stock. Avanos Medical Stock Performance Shares of AVNS stock opened at $20.39 on Monday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.47 and a current ratio of 2.28. The company has a market capitalization of $935.98 million, a price-to-earnings ratio of -15.33 and a beta of 0.97. Avanos Medical, Inc. has a one year low of $17.24 and a one year high of $26.56. The company’s 50-day moving average is $19.34 and its 200 day moving average is $20.02. Avanos Medical (NYSE:AVNS – Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.02). The firm had revenue of $166.10 million for the quarter, compared to the consensus estimate of $162.90 million. Avanos Medical had a negative net margin of 9.15% and a positive return on equity of 4.10%. Avanos Medical’s revenue was up 4.3% on a year-over-year basis. During the same period last year, the business earned $0.27 EPS. Sell-side analysts expect that Avanos Medical, Inc. will post 1.38 EPS for the current fiscal year. Avanos Medical Profile (Free Report) Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
- 05/20/2024
|
Avanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply Chain
- ALPHARETTA, Ga. , May 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sigfrido (Sig) Delgado has been appointed senior vice president, integrated supply chain.
- 05/13/2024
|
Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q1 2024 Earnings Conference Call May 2, 2024 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Daniel Stauder - JMP Securities Operator Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At this time, all lines are in a listen-only mode.
- 05/05/2024
|
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
- Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
- 05/03/2024
|
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
- Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share from continuing operations, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.13 per share a year ago.
- 05/03/2024
|
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
- Avanos Medical (AVNS) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.27 per share a year ago.
- 05/02/2024
|
Avanos Medical, Inc. Announces First Quarter 2024 Results
- ALPHARETTA, Ga. , May 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2024 financial results.
- 05/02/2024
|
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
- ALPHARETTA, Ga. , April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m.
- 04/25/2024
|
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
- Avanos' (AVNS) strong product line and focus on R&D raise optimism about the stock.
- 04/02/2024
|
Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall
- ALPHARETTA, Ga. , Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024.
- 02/21/2024
|
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
- Despite strength in Avanos' (AVNS) Digestive Health segment, its overall fourth-quarter results reflect soft performances.
- 02/21/2024
|
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results
- ALPHARETTA, Ga. , Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results.
- 02/20/2024
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
- ALPHARETTA, Ga. , Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m.
- 02/13/2024
|
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / February 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 02/12/2024
|
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / January 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 01/21/2024
|
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- NEW YORK, NY / ACCESSWIRE / January 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 01/18/2024
|
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 01/17/2024
|
New Strong Sell Stocks for January 16th
- AMFPF, ADI and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 16, 2024.
- 01/16/2024
|
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / January 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 01/16/2024
|
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm
- LOS ANGELES, CA / ACCESSWIRE / January 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avanos Medical, Inc. ("Avanos" or "the Company") (NYSE:AVNS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 01/15/2024
|
New Strong Sell Stocks for January 12th
- AIR, AVNS and BP have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2024.
- 01/12/2024
|
New Strong Sell Stocks for January 9th
- AIR, AMSF and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 9, 2024.
- 01/09/2024
|
Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- ALPHARETTA, Ga. , Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42nd Annual J.P.
- 01/02/2024
|
Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
- 12/01/2023
|
Avanos Medical, Inc. to Present at the Stifel 2023 Healthcare Conference
- ALPHARETTA, Ga. , Nov. 7, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m.
- 11/07/2023
|
Avanos Medical Inc. (AVNS) Q3 2023 Earnings Call Transcript
- Avanos Medical Inc. (NYSE:AVNS ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Company Participants Scott Galovan - SVP, Strategy and Corporate Development Joseph Woody - CEO Michael Greiner - Senior VP, CFO and Chief Transformation Officer Conference Call Participants Rick Wise - Stifel Kristen Stewart - CL King Daniel Stauder - JMP Securities Operator Good morning, and welcome to Avanos' Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
- 11/04/2023
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2023 Financial Results
- ALPHARETTA, Ga. , Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on Wednesday, Nov. 1 at 9 a.m.
- 10/25/2023
|
Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference
- ALPHARETTA, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 21st Annual Best Ideas Conference 2023 on Mon.
- 09/12/2023
|
Avanos (AVNS) Q2 Earnings and Revenues Fall Shy of Estimates
- Despite strength in Avanos' (AVNS) Digestive Health segment, its overall second-quarter results reflect soft performances.
- 08/10/2023
|
Avanos Medical Inc. (AVNS) Q2 2023 Earnings Call Transcript
- Avanos Medical Inc. (NYSE:AVNS ) Q2 2023 Results Conference Call August 9, 2023 9:00 AM ET Company Participants Joe Woody - CEO and Director Scott Galovan - Vice President of Strategy and Corporate Development Michael Greiner - Senior VP, CFO and Chief Transformation Officer Conference Call Participants Rick Wise - Stifel Matthew Mishan - KeyBanc Kristen Stewart - CL King Daniel Stauder - JMP Securities Operator Good morning, everyone, and welcome to the Avanos Second Quarter 2023 Earnings Conference Call. All participants are in a listen-only mode.
- 08/09/2023
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2023 Financial Results
- ALPHARETTA, Ga. , Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m.
- 08/02/2023
|
AVNS vs. EW: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Avanos Medical (AVNS) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
- 07/24/2023
|
Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
- Avanos Medical, Inc. (AVNS) continues its focus on a leaner cost structure and repurposing of capital. The struggling respiratory health business has been sold off, with the transaction due to settle in Q4 this year. Despite financial headwinds, AVNS is increasing capital productivity and my number project $802.8mm and $833mm in sales in FY'23 and FY'24, respectively.
- 07/16/2023
|
Avanos' (AVNS) Latest Buyout to Boost Its RF Product Offering
- Avanos' (AVNS) latest acquisition is expected to strengthen its foothold with a comprehensive suite of RF offerings.
- 06/21/2023
|
Avanos (AVNS) Q1 Earnings and Revenues Fall Shy of Estimates
- Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.
- 05/05/2023
|
Avanos Medical (AVNS) Q1 Earnings and Revenues Lag Estimates
- Avanos Medical (AVNS) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.26 per share a year ago.
- 05/03/2023
|
Avanos Medical: Cost Restructuring Could Unlock Substantial Value
- Avanos Medical: Cost Restructuring Could Unlock Substantial Value.
- 04/21/2023
|
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 04/13/2023
|
BRKR's Canopy Biosciences Partners With Enable Medicine
- BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.
- 04/13/2023
|
Is Avanos Medical (AVNS) Outperforming Other Medical Stocks This Year?
- Here is how Avanos Medical (AVNS) and Becton Dickinson (BDX) have performed compared to their sector so far this year.
- 04/07/2023
|
3 Reasons to Add Avanos (AVNS) Stock to Your Portfolio
- Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
- 04/06/2023
|
Avanos Medical, Inc. to Present at the 2023 Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- ALPHARETTA, Ga. , March 15, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer and chief transformation officer, will present and participate in an analyst-led fireside chat at the 2023 virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wed.
- 03/15/2023
|
Should Value Investors Buy Avanos Medical (AVNS) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/02/2023
|
What Makes Avanos Medical (AVNS) a New Buy Stock
- Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/24/2023
|
Avanos (AVNS) Q4 Earnings Surpass Estimates, Margins Up
- Avanos' (AVNS) fourth-quarter 2022 results reflect strength in both segments.
- 02/22/2023
|
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/22/2023
|
Avanos Medical, Inc. (AVNS) Q4 2022 Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q4 2022 Earnings Conference Call February 21, 2023 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy and M&A Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President, Chief Financial Officer and CTO Conference Call Participants Rick Wise - Stifel Matthew Mishan - KeyBanc Drew Ranieri - Morgan Stanley Dave Turkaly - JMP Securities Operator Good day. And welcome to the Avanos Fourth Quarter 2022 Earnings Conference Call.
- 02/21/2023
|
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/21/2023
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial Results
- ALPHARETTA, Ga. , Feb. 14, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2022 on Tuesday, Feb. 21 at 9 a.m.
- 02/14/2023
|
Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
- ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P.
- 01/04/2023
|
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
- Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
- 12/09/2022
|
3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
- Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
- 12/08/2022
|
Avanos: TriVisc Offering Appealing, Strong Growth Across Rest Of Product Portfolio, Revise To Buy
- Revenue for the third quarter 2022 was $202mm, up 9.8% compared to last year. Substantial uplift in operating income, fetching $27mm, representing YoY growth of ~59%.
- 12/06/2022
|
Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
- 12/02/2022
|
Avanos Medical, Inc. to Present at the Stifel 2022 Healthcare Conference
- ALPHARETTA, Ga. , Nov. 8, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present at the Stifel 2022 Healthcare Conference on Tuesday, Nov. 15 at approximately 3:35 p.m.
- 11/08/2022
|
Avanos Medical, Inc. (AVNS) Q3 2022 - Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Scott Galovan - Vice President, Corporate Strategy and Business Development Joseph Woody - Chief Executive Officer Michael Greiner - Senior Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Brett Fishbin - KeyBanc Operator Good morning, and welcome to the Avanos Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
- 11/05/2022
|
Avanos (AVNS) Q3 Earnings Surpass Estimates, Margins Up
- Avanos' (AVNS) third-quarter 2022 results reflect strength in the Pain Management segment.
- 11/04/2022
|
Avanos Medical (AVNS) Tops Q3 Earnings Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.56% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/02/2022
|
New Strong Sell Stocks for October 5th
- AVNS, NKE and PLAB have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2022.
- 10/05/2022
|
New Strong Sell Stocks for September 28th
- AVNS, ARCE and DCO have been added to the Zacks Rank #5 (Strong Sell) List on September 28, 2022.
- 09/28/2022
|
Avanos Medical (AVNS) Down 14% Since Last Earnings Report: Can It Rebound?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
- 09/08/2022
|
Avanos Medical, Inc. To Present at the Morgan Stanley 20th Annual Global Healthcare Conference
- ALPHARETTA, Ga. , Sept. 7, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present and participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, Sept.
- 09/07/2022
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2022 Results - Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Scott Galovan - Vice President, Corporate Strategy and Business Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Matthew Mishan - KeyBanc Chris Cooley - Stephens Drew Ranieri - Morgan Stanley Operator Good day, and welcome to Avanos Second Quarter 2020 Earnings Call. All participants will be in a listen-only mode.
- 08/12/2022
|
7 Safe Small-Cap Stocks to Buy Now
- Let's begin by defining the realm of small-cap stocks before we discuss those that appear to be strong, safe investments currently. As their name implies, small-cap stocks have lower market capitalizations than both mid-cap and large-cap stocks.
- 08/10/2022
|
Avanos (AVNS) Q2 Earnings Top Estimates, FY22 View Lowered
- Avanos's (AVNS) second-quarter 2022 results reflect strength in the Pain Management segment.
- 08/10/2022
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2022 Financial Results
- ALPHARETTA, Ga. , July 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2022 on Tuesday, August 9 at 9 a.m.
- 07/27/2022
|
7 Undervalued Small-Cap Stocks to Buy Now
- These undervalued small-cap stocks to buy do have value and could outperform in both the short term and long term. The post 7 Undervalued Small-Cap Stocks to Buy Now appeared first on InvestorPlace.
- 07/24/2022
|
Can Avanos Medical (AVNS) Keep the Earnings Surprise Streak Alive?
- Avanos Medical (AVNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/20/2022
|
3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
- Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
- 07/08/2022
|
Here's Why You Should Hold on to Avanos (AVNS) Stock For Now
- Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
- 06/07/2022
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2022 Results - Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS ) Q1 2022 Earnings Conference Call May 7, 2022 9:00 AM ET Company Participants Scott Galovan - Vice President, Corporate Strategy and Business Development Joe Woody - Chief Executive Officer Michael Greiner - Senior Vice President and Chief Financial Officer Conference Call Participants Chris Cooley - Stephens Matthew Mishan - KeyBanc Rick Wise - Stifel Drew Ranieri - Morgan Stanley Operator Good morning. And welcome to Avanos First Quarter 2022 Earnings Call.
- 05/08/2022
|
Avanos Medical (AVNS) Q1 Earnings, Revenues Top Estimates
- Avanos Medical's (AVNS) first-quarter 2022 results reflect strength in the Pain Management segment.
- 05/06/2022
|
Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 8.33% and 0.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2022
|
Love Dirt-Cheap Growth Stocks? Check Out This Under-The-Radar Buy
- There's a reason why it's so cheap, but it isn't a deal breaker.
- 05/01/2022
|
Is Avanos Medical (AVNS) Stock Outpacing Its Medical Peers This Year?
- Here is how Avanos Medical (AVNS) and Axcella Health Inc. (AXLA) have performed compared to their sector so far this year.
- 04/04/2022
|
Avanos Medical, Inc. to Present at the Virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum
- ALPHARETTA, Ga., March 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer, will present and participate in an analyst-led fireside chat at the virtual KeyBanc 2022 Life Sciences & MedTech Investor Forum on Tues.
- 03/15/2022
|
New Strong Buy Stocks for March 11th
- ABM, AVNS, ASIX, AA, and ESEA have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2022.
- 03/11/2022
|
Avanos Medical's (AVNS) CEO Joe Woody on Q4 2021 Results - Earnings Call Transcript
- Avanos Medical's (AVNS) CEO Joe Woody on Q4 2021 Results - Earnings Call Transcript
- 02/23/2022
|
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 15% and 1.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/23/2022
|
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
- ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2021 on Wednesday, Feb. 23 at 9 a.m.
- 02/15/2022
|
Avanos Medical (AVNS) Earnings Expected to Grow: What to Know Ahead of Q4 Release
- Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/10/2022
|
New Strong Sell Stocks for January 24th
- AGNC, AVNS, and SQ have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2022
- 01/24/2022
|
New Strong Sell Stocks for January 19th
- ONEM, ALXO, and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 19, 2022
- 01/19/2022
|
Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
- ALPHARETTA, Ga., Jan. 10, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 40th Annual J.P.
- 01/10/2022
|
Avanos Medical's (AVNS) App to Support Pain Management Process
- Avanos Medical's (AVNS) new solution to help healthcare providers with respect to patients' overall pain management process.
- 12/06/2021
|
Avanos Medical (AVNS) Down 17.6% Since Last Earnings Report: Can It Rebound?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
- 12/02/2021
|
Avanos Medical (AVNS) Q3 Earnings Lag Estimates, Revenues Top
- Avanos Medical's (AVNS) third-quarter 2021 results gains from strength in the Pain Management segment.
- 11/03/2021
|
Avanos Medical (AVNS) to Report Q3 Results: Wall Street Expects Earnings Growth
- Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/26/2021
|
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2021 Financial Results
- ALPHARETTA, Ga., Oct. 26, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2021 on Tuesday, Nov. 2 at 9 a.m.
- 10/26/2021
|
Why Is Avanos Medical (AVNS) Down 2.2% Since Last Earnings Report?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
- 09/02/2021
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2021 Results - Earnings Call Transcript
- Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2021 Results - Earnings Call Transcript
- 08/03/2021
|
Avanos Medical Shares Fall As Higher Transportation Costs Hit Q2 Margins; Lowers FY21 Guidance
- Avanos Medical Inc (NYSE: AVNS) reported a second-quarter FY21 adjusted EPS of $0.21, missing the consensus of $0.23. The sales of $186.4 million increased 14% Y/Y, beating the analyst estimate of $180.6 million.
- 08/03/2021
|
Avanos Medical: Q2 Earnings Insights
- Shares of Avanos Medical (NYSE:AVNS) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 61.54% year over year to $0.21, which missed the estimate of $0.23.
- 08/03/2021
|
Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
- Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/27/2021
|
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2021 Financial Results
- ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tuesday, August 3 at 9 a.m.
- 07/27/2021
|
Here's Why You Should Retain Avanos (AVNS) Stock for Now
- Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
- 07/15/2021
|
Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General Counsel
- ALPHARETTA, Ga., July 12, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Moji James has been appointed senior vice president & general counsel.
- 07/12/2021
|
Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference
- ALPHARETTA, Ga., June 18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues.
- 06/18/2021
|
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
- Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the first quarter.
- 05/10/2021
|
Avanos Medical, Inc.'s (AVNS) CEO Joe Woody on Q1 2021 Results - Earnings Call Transcript
- Avanos Medical, Inc.'s (AVNS) CEO Joe Woody on Q1 2021 Results - Earnings Call Transcript
- 05/07/2021
|
Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.78% and 2.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2021
|
Avanos Medical, Inc. Announces First Quarter 2021 Results
- ALPHARETTA, Ga., May 7, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2021 financial results.
- 05/07/2021
|
Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2021 Financial Results
- ALPHARETTA, Ga., April 30, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Friday, May 7 at 9 a.m.
- 04/30/2021
|
Avanos Medical, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
- ALPHARETTA, Ga., March 16, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Virtual KeyBanc Life Sciences & MedTech Investor Forum Tues.
- 03/16/2021
|
Here's Why You Should Retain Avanos Medical (AVNS) Stock Now
- Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.
- 02/24/2021
|
Avanos Medical (AVNS) Q4 Earnings and Revenues Top Estimates
- Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.
- 02/19/2021
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2020 Results - Earnings Call Transcript
- Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2020 Results - Earnings Call Transcript
- 02/18/2021
|
Recap: Avanos Medical Q4 Earnings
- Shares of Avanos Medical (NYSE:AVNS) rose 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 17.65% year over year to $0.28, which beat the estimate of $0.22.
- 02/18/2021
|
Why You Should Retain Avanos Medical (AVNS) Stock for Now
- Investor confidence is high on Avanos Medical (AVNS), courtesy of solid prospects.
- 12/21/2020
|
Avanos Medical's (AVNS) CEO Joe Woody on Q3 2020 Results - Earnings Call Transcript
- Avanos Medical's (AVNS) CEO Joe Woody on Q3 2020 Results - Earnings Call Transcript
- 11/03/2020
|
Avanos Medical, Inc. Announces Third Quarter 2020 Results
- ALPHARETTA, Ga., Nov. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2020 financial results. "Thanks to the work of our team and their focus on execution, our momentum continued as we delivered results ahead of our expectations," stated Joe Woody,...
- 11/03/2020
|
Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2020 Financial Results
- ALPHARETTA, Ga., Oct. 27, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2020 on Tuesday, Nov. 3 at 9 a.m. ET. The company will issue a news release detailing its results...
- 10/27/2020
|
Cardiovascular Interventional Devices Market Developments, Competitive Analysis, Forecasts 2026
- Oct 09, 2020 (Market Insight Reports) --
Global Cardiovascular Interventional Devices Market Research Report 2020 begins with an overview of the Market and...
- 10/09/2020
|
Interventional Radiology Market Size, Growth, Trends, Company Analysis and Forecast 2020 to 2030
- Oct 08, 2020 (Profound via COMTEX) --
InsightSLICE report, titled Global Interventional Radiology Market Size, Share, Growth, Trends, Company Analysis and...
- 10/08/2020
|
Interventional Radiology Market Emerging Trends, Revenue Estimation, Global Size and Forecast Report to 2025
- Oct 07, 2020 (Heraldkeepers) --
The Interventional Radiology Market is segmented on the lines of its product, procedure, application and regional. Based on...
- 10/07/2020
|
Principal Financial Group Inc. Buys 3,993 Shares of Avanos Medical Inc (NYSE:AVNS)
- Principal Financial Group Inc. boosted its stake in shares of Avanos Medical Inc (NYSE:AVNS) by 2.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 153,948 shares of the company’s stock after purchasing an additional 3,993 shares during […]
- 10/04/2020
|
Handelsbanken Fonder AB Invests $239,000 in Avanos Medical Inc (NYSE:AVNS)
- Handelsbanken Fonder AB bought a new position in Avanos Medical Inc (NYSE:AVNS) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 8,116 shares of the company’s stock, valued at approximately $239,000. Several other institutional investors have also recently added to or reduced their stakes in AVNS. First Trust Advisors LP increased its position in shares […]
- 10/02/2020
|
AQR Capital Management LLC Acquires 12,787 Shares of Avanos Medical Inc (NYSE:AVNS)
- AQR Capital Management LLC boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 92.6% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,597 shares of the company’s stock after acquiring an additional 12,787 shares during the quarter. AQR Capital Management LLC owned 0.06% […]
- 10/02/2020
|
Interventional Cardiology & Peripheral Vascular Devices Market Report 2020: Manufacturers, Countries, Type and Application, Global Forecast To 2025
- Sep 10, 2020 (Heraldkeepers) --
Interventional cardiology offers with catheter-based totally technologies for the remedy of structural heart sicknesses. The...
- 09/10/2020
|
Avanos Medical Inc (NYSE:AVNS) Stock Holdings Boosted by Marshall Wace North America L.P.
- Marshall Wace North America L.P. lifted its position in shares of Avanos Medical Inc (NYSE:AVNS) by 29.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 47,595 shares of the company’s stock after acquiring an additional 10,785 shares during the period. Marshall Wace North America L.P.’s holdings in […]
- 09/10/2020
|
Interventional Cardiology & Peripheral Vascular Devices Market Forecast Revised in a New Big Market Research Report as COVID-19 Projected to Hold a Massive Impact on Sales in 2019
- Aug 28, 2020 (Heraldkeepers) --
Interventional cardiology offers with catheter-based totally technologies for the remedy of structural heart sicknesses. The...
- 08/28/2020
|
COVID-19 Pandemic Impact on Global Enteral Syringe Market 2020-2024 | Technavio
- The Global Enteral Syringe Market will grow by USD 196.72 mn during 2020-2024
- 08/26/2020
|
Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates
- Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.
- 08/10/2020
|
Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates
- Stocks Analysis by Zacks Investment Research covering: Thermo Fisher Scientific Inc, PerkinElmer Inc, West Pharmaceutical Services Inc, Avanos Medical Inc. Read Zacks Investment Research's latest article on Investing.com
- 08/10/2020
|
Avanos Medical, Inc. (AVNS) Q2 2020 Earnings Call Transcript
- Image source: The Motley Fool. Avanos Medical, Inc. (NYSE: AVNS)Q2 2020 Earnings CallAug 4, 2020, 9:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the Avanos Second Quarter 2020 Earnings Conference Call.
- 08/04/2020
|
Avanos Medical, Inc. Announces Second Quarter 2020 Results
- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2020 financial results.
- 08/04/2020
|
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
- 08/04/2020
|
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
- Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
- 08/02/2020
|
Avanos Medical (AVNS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/28/2020
|
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2020 Financial Results
- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2020 on Tuesday, Aug. 4 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day.
- 07/28/2020
|
North Star Investment Management Corp. Has $36,000 Position in Avanos Medical Inc (NYSE:AVNS)
- North Star Investment Management Corp. lowered its position in shares of Avanos Medical Inc (NYSE:AVNS) by 46.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,213 shares of the company’s stock after selling 1,065 shares during the period. North Star Investment Management Corp.’s holdings […]
- 07/19/2020
|
Analysis on New Product Launches in COVID-19 Related Markets: Enteral Syringe Market - Vendor Analysis and growth outlook for 2020-2024: Exclusive Report from Technavio
- The Global Enteral Syringe Market will grow by USD 196.72 mn during 2020-2024
- 07/14/2020
|
Here's Why You Should Retain Avanos Medical Stock for Now
- Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.
- 07/08/2020
|
Invesco Ltd. Lowers Stake in Avanos Medical Inc (NYSE:AVNS)
- Invesco Ltd. lowered its stake in shares of Avanos Medical Inc (NYSE:AVNS) by 80.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 261,979 shares of the company’s stock after selling 1,099,153 shares during the period. Invesco Ltd. owned 0.55% […]
- 07/06/2020
|
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the closing of concurrent $150 million private equity and debt financings, consisting of an equity financing pursuant to a Securities Purchase Agreement with an entity controlled by EW Healthcare Partners and certain funds managed by Hayfin Capital Management LLP (“Hayfin”), and a debt financing pursuant to a Loan Agreement with Hayfin. As part of the transaction, EW Healthcare Partners has designated Martin P. Sutter and William A. Hawkins III to serve on the Company’s board as preferred directors.
- 07/02/2020
|
Global Peptic Ulcer Testing Industry (2019 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com
|
Hedge Funds Are Piling Into Avanos Medical (AVNS)
- The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
- 06/28/2020
|
Avanos Medical Inc (NYSE:AVNS) Stake Raised by Deutsche Bank AG
- Deutsche Bank AG boosted its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 94.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 114,958 shares of the company’s stock after acquiring an additional 55,805 shares during the quarter. Deutsche Bank AG owned 0.24% of […]
- 06/24/2020
|
Bayer Consumer Health Makes Leadership Changes
- Two top Bayer Consumer Health executives are taking on new responsibilities due to strategic moves the business is making in its executive team to str
- 06/23/2020
|
Assessment of COVID-19's Effect on Enteral Feeding Devices Market 2020-2024 | Growing Number of Strategic Alliances to Augment Growth | Technavio
- The Global Enteral Feeding Devices Market 2020-2024 will grow by USD 1.07 bn during 2020-2024
- 06/19/2020
|
Avanos Medical Inc (NYSE:AVNS) Short Interest Update
- Avanos Medical Inc (NYSE:AVNS) was the target of a significant decline in short interest during the month of May. As of May 29th, there was short interest totalling 2,370,000 shares, a decline of 13.8% from the May 14th total of 2,750,000 shares. Based on an average daily trading volume, of 430,000 shares, the short-interest ratio […]
- 06/14/2020
|
Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/05/2020
|
Edited Transcript of AVNS earnings conference call or presentation 6-May-20 1:00pm GMT
- Q1 2020 Avanos Medical Inc Earnings Call
- 06/03/2020
|
The Rise and Potential of Gut Health | Market Research Blog
- Interest in food as medicine grows as consumers suffering from lower digestive health issues opt for prevention over treatment.
- 05/30/2020
|
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in June
- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June:
- 05/28/2020
|
Helicobacter Pylori Testing Market 2020 Overview by Experts – Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories
- Global Helicobacter Pylori Testing Market Insights, Forecast to 2025 May 26, 2020 (Market Insight Reports) --
Helicobacter Pylori Testing Market report will...
- 05/26/2020
|
Edited Transcript of AVNS earnings conference call or presentation 6-May-20 1:00pm GMT
- Q1 2020 Avanos Medical Inc Earnings Call
- 05/23/2020
|
Here's Why You Should Retain Avanos Medical Stock for Now
- Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.
- 05/18/2020
|
Analysis on Impact of COVID-19-Global Enteral Syringe Market 2020-2024 | Evolving Opportunities with Amsino International Inc. and Avanos Medical Inc. | Technavio
- The enteral syringe market size has the potential to grow by USD 196.72 million during 2020-2024
- 05/14/2020
|
Insights into the Worldwide Enteral Syringe Industry to 2024 - Key Trends, Growth Drivers and Challenges - ResearchAndMarkets.com
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS) Q1 2020 Earnings Conference Call May 06, 2020, 09:00 AM ET Company Participants Dave Crawford - Vice President of Investor Rela
- 05/09/2020
|
Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top
- Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.
- 05/08/2020
|
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
- Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGHLIGHTS
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Lyft Inc : Piper Sandler cuts to neutral from overweight
* Natera Inc : JP Morgan raises to overweight from neutral
* Occidental Petroleum Corp : SunTrust Robinson raises to hold from sell
* Solaredge Technologies : Canaccord Genuity cuts to hold from buy
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.
* A. O. Smith Corp : Stephens raises target price to $40 from $37
* Acadia Healthcare Company Inc : Citigroup cuts price target to $34 from $37
* Acadia Healthcare Company Inc : Deutsche Bank cuts target price to $28 from $32
* Activision Blizzard Inc : Keybanc raises target price to $80 from $68
* Adient Plc : Deutsche Bank raises target price to $20 from $15
* ADMA Biologics Inc : Oppenheimer cuts target price to $7 from $14
* Advanced Energy Industries Inc : Citigroup raises price target to $63 from $40
* Advanced Energy Industries Inc : Cowen and Company raises PT to $58 from $51
* Advanced Energy Industries Inc : D.A. Davidson raises target to $60 from $50
* Advanced Energy Industries Inc : Susquehanna cuts target price to $85 from $90
* Aerie Pharmaceuticals Inc : H.C. Wainwright cuts target price to $31 from $37
* Aerie Pharmaceuticals Inc : Mizuho cuts target price to $29 from $34
* Aerie Pharmaceuticals Inc : Piper Sandler cuts target price to $35 from $45
* Aerie Pharmaceuticals Inc : SunTrust Robinson cuts price target to $22 from $26
* Agco Corp : Stephens raises target price to $65 from $60
* Air Transport Services Group Inc : Cowen and Company raises PT to $26 from $25
* Albemarle Corp : UBS cuts target price to $90 from $98
* Alexion Pharmaceuticals Inc : BMO cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Credit Suisse cuts target price to $142 from $147
* Alexion Pharmaceuticals Inc : Jefferies cuts price target to $111 from $112
* Alexion Pharmaceuticals Inc : Raymond James cuts target price to $156 from $159
* Alexion Pharmaceuticals Inc : SunTrust Robinson cuts target to $135 from $141
* Alexion Pharmaceuticals Inc : SVB Leerink cuts target price to $150 from $156
* Allegiant Travel Co : Cowen and Company cuts price target to $74 from $100
* Allete Inc : Guggenheim cuts price target to $65 from $70
* Allogene Therapeutics Inc : Jefferies raises target price to $37 from $36
* Allstate Corp : Piper Sandler raises target price to $112 from $108
* Alnylam Pharmaceuticals Inc : Guggenheim raises price target to $166 from $155
* Alnylam Pharmaceuticals Inc : BMO raises target price to $171 from $145
* Alnylam Pharmaceuticals Inc : Jefferies raises price target to $165 from $142
* Alnylam Pharmaceuticals Inc : JP Morgan cuts to neutral from overweight
* Alnylam Pharmaceuticals Inc : JP Morgan raises target price to $137 from $133
* Alnylam Pharmaceuticals Inc : Needham raises target price to $160 from $135
* Alnylam Pharmaceuticals Inc : Oppenheimer raises target price to $162 from $140
* Alnylam Pharmaceuticals Inc : Piper Sandler raises target to $169 from $142
* Alteryx Inc : Citigroup cuts price target to $147 from $160
* Alteryx Inc : Cowen and Company cuts target price to $135 from $145
* Alteryx Inc : Needham cuts target price to $140 from $152
* Alteryx Inc : Wedbush cuts price target to $138 from $146
* Amedisys Inc : Benchmark cuts to hold rating
* Ameriprise Financial Inc : Evercore ISI raises target price to $139 from $136
* Ametek Inc : Berenberg raises target price to $93 from $86
* Ametek Inc : Stephens cuts target price to $92 from $94
* Anaptysbio Inc : Credit Suisse raises target price to $16 from $14
* Apache Corp : Credit Suisse raises target price to $10 from $4
* Aptiv Plc : Deutsche Bank raises target price to $75 from $59
* Arcus Biosciences Inc : Wedbush raises target price to $40 from $26
* Ares Capital Corp : BMO cuts target price by $5 to $16
* Ares Capital Corp : Citigroup raises price target to $15 from $13
* Ares Management Corp : BMO raises target price to $40 from $30
* Ares Management Corp : Credit Suisse raises target price to $40 from $38
* Ares Management Corp : Jefferies raises target price to $42 from $39
* Ares Management Corp : KBW raises target price to $45 from $44
* ASGN Inc : Jefferies raises target price to $54 from $31
* Ashland Global Holdings Inc : Deutsche Bank raises target price to $70 from $65
* Ashland Global Holdings Inc. : JP Morgan cuts target price to $62 from $68
* Ashland Global Holdings Inc. : JP Morgan raises to neutral from underweight
* Ashland Global Holdings Inc. : SunTrust Robinson cuts price target to $75 from $87
* Aspen Technology Inc : Benchmark cuts target price to $130
* Aspen Technology Inc : Keybanc raises target price to $120 from $110
* Assetmark Financial Holdings Inc : BMO cuts target price to $23 from $26
* Assurant Inc : SunTrust Robinson cuts price target to $145 from $155
* Astronics Corp : Canaccord Genuity cuts target price to $10 from $14
* Astronics Corp : SunTrust Robinson cuts price target to $6 from $7
* Atkore International Group Inc : Citigroup raises price target to $26 from $24
* Atlas Corp (British Columbia) : Citigroup cuts price target to $7 from $12
* Avanos Medical Inc : Berenberg raises target price to $33 from $30
* Avanos Medical Inc : Stephens raises target price to $38 from $30
* Axalta Coating Systems Ltd : Citigroup raises price target to $21 from $18
* Axalta Coating Systems Ltd : Credit Suisse cuts target price to $27 from $29
* Axalta Coating Systems Ltd : Jefferies raises target price to $18 from $15
* Axalta Coating Systems Ltd : Keybanc raises target price to $24 from $23
* Axcelis Technologies Inc : D.A. Davidson raises price target to $25 from $20
* Axcella Health Inc : BTIG raises target price to $12 from $10
* Axogen Inc : Canaccord Genuity cuts target price to $12 from $22
* Axogen Inc : Jefferies cuts target price to $21 from $30
* Bank of N.T. Butterfield & Son Ltd : Citigroup raises target to $21 from $15
* Barrett Business Services Inc : Barrington Research raises PT to $52 from $48
* Barrick Gold Corp : Deutsche Bank raises target price to $34 from $25
* Benefitfocus Inc : Piper Sandler cuts target price to $26 from $35
* Bio Rad Laboratories Inc : Citigroup raises price target to $525 from $480
* Bio Rad Laboratories Inc : Jefferies raises target price to $525 from $500
* Biocryst Pharmaceuticals Inc : Jefferies raises price target to $9 from $8
* Biocryst Pharmaceuticals Inc : Piper Sandler raises target price to $10 from $8
* Biotelemetry Inc : Benchmark cuts target price to $52 from $55
* Black Knight Inc : KBW raises target price to $70 from $68
* Black Knight Inc : Stephens raises target price to $88 from $84
* Black Knight Inc : Wedbush raises target price to $70 from $66
* Black Stone Minerals LP : Simmons Energy raises target price to $8 from $5
* Blackbaud Inc : Evercore ISI cuts target price to $48 from $55
* Blucora Inc : Benchmark cuts price target to $25 from $37
* BMC stock Holdings Inc : Stephens raises target price to $25 from $22
* BMC stock Holdings Inc : SunTrust Robinson raises price target to $26 from $22
* BorgWarner Inc : Jefferies raises target price to $33 from $30
* BorgWarner Inc : JP Morgan raises price target to $35 from $32
* BorgWarner Inc : Oppenheimer cuts target price to $44 from $45
* BorgWarner Inc : RBC raises target price to $31 from $29
* Boston Private Financial Holdings Inc : Piper Sandler raises PT to $7 from $6.
- 05/07/2020
|
Avanos Medical, Inc. (AVNS) Q1 2020 Earnings Call Transcript
- AVNS earnings call for the period ending March 31, 2020.
- 05/06/2020
|
Avanos Medical: Q1 Earnings Insights
- Shares of Avanos Medical (NYSE:AVNS) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 6.67% over the past year to $0.16, which were in line with the estimate of $0.16.Revenue of $180,400,000 rose by 9.87% year over year, which beat the estimate of $175,220,000.Outlook Avanos Medical hasn't issued any earnings guidance for the time being.Avanos Medical hasn't issued any revenue guidance for the time being.Conference Call Details Date: May 06, 2020View more earnings on AVNSWebcast URL: https://www.webcaster4.com/Webcast/Page/939/34129Technicals Company's 52-week high was at $48.0752-week low: $19.46Price action over last quarter: down 8.19%Company Profile Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.See more from Benzinga * IEC Electronics: Q2 Earnings Insights * Recap: RPC Q1 Earnings * Recap: Sinclair Broadcast Group Q1 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 05/06/2020
|
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/06/2020
|
Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic
- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.
- 05/06/2020
|
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
- Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
- 05/06/2020
|
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
- Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
- 05/03/2020
|
Avanos Medical Inc (NYSE:AVNS) Short Interest Up 12.0% in April
- Avanos Medical Inc (NYSE:AVNS) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,810,000 shares, an increase of 12.0% from the March 31st total of 2,510,000 shares. Currently, 6.0% of the company’s shares are short sold. Based on an average daily volume of […]
- 05/02/2020
|
CLOROX : DE/ Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | MarketScreener
|
Clorox : Reports Q3 Fiscal Year 2020 Results, Updates Fiscal Year Outlook | MarketScreener
|
Does Avanos Medical, Inc. (NYSE:AVNS) Have A Particularly Volatile Share Price?
- If you're interested in Avanos Medical, Inc. (NYSE:AVNS), then you might want to consider its beta (a measure of share...
- 04/30/2020
|
Avanos Medical (NYSE:AVNS) PT Lowered to $45.00 at KeyCorp
- Avanos Medical (NYSE:AVNS) had its target price lowered by KeyCorp from $48.00 to $45.00 in a research report sent to investors on Monday morning, BenzingaRatingsTable reports. The firm currently has an overweight rating on the stock. KeyCorp also issued estimates for Avanos Medical’s Q1 2020 earnings at $0.13 EPS, Q2 2020 earnings at ($0.02) EPS, […]
- 04/30/2020
|
Q2 2020 EPS Estimates for Avanos Medical Inc Reduced by Analyst (NYSE:AVNS)
- Avanos Medical Inc (NYSE:AVNS) – Analysts at KeyCorp decreased their Q2 2020 EPS estimates for Avanos Medical in a research note issued on Sunday, April 26th. KeyCorp analyst M. Mishan now anticipates that the company will post earnings per share of ($0.02) for the quarter, down from their prior forecast of $0.27. KeyCorp has a […]
- 04/29/2020
|
Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
- Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
- Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Equities Analysts Issue Forecasts for Avanos Medical Inc's Q1 2020 Earnings (NYSE:AVNS)
- Avanos Medical Inc (NYSE:AVNS) – Research analysts at KeyCorp decreased their Q1 2020 EPS estimates for Avanos Medical in a research note issued on Sunday, April 26th. KeyCorp analyst M. Mishan now anticipates that the company will post earnings per share of $0.13 for the quarter, down from their previous estimate of $0.15. KeyCorp currently […]
- 04/28/2020
|
Avanos Medical (AVNS) Receives a Buy from KeyBanc
- In a report released today, Matthew Mishan from KeyBanc maintained a Buy rating on Avanos Medical (AVNS), with a price target of $45.00. The company's
- 04/27/2020
|
Avanos Medical (AVNS) Receives a Buy from KeyBanc
- In a report released today, Matthew Mishan from KeyBanc maintained a Buy rating on Avanos Medical (AVNS – Research Report),
- 04/27/2020
|
North Star Asset Management Inc. Purchases 865 Shares of Avanos Medical Inc (NYSE:AVNS)
- North Star Asset Management Inc. increased its position in Avanos Medical Inc (NYSE:AVNS) by 3.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,996 shares of the company’s stock after acquiring an additional 865 shares during the quarter. North Star Asset Management Inc. […]
- 04/27/2020
|
Brokerages Expect Avanos Medical Inc (NYSE:AVNS) Will Post Quarterly Sales of $175.57 Million
- Equities analysts expect Avanos Medical Inc (NYSE:AVNS) to announce sales of $175.57 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Avanos Medical’s earnings. The highest sales estimate is $179.70 million and the lowest is $169.20 million. Avanos Medical reported sales of $164.20 million during the same quarter last year, […]
- 04/23/2020
|
Were Hedge Funds Right About LGI Homes Inc (LGIH)?
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 04/18/2020
|
Were Hedge Funds Right About The RealReal, Inc. (REAL)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Were Hedge Funds Right About Tronox Limited (TROX)?
- Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to […]
- 04/18/2020
|
Were Hedge Funds Right About Cardlytics, Inc. (CDLX)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Were Hedge Funds Right About Avanos Medical (AVNS)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Norges Bank Invests $21.96 Million in Avanos Medical Inc (NYSE:AVNS)
- Norges Bank acquired a new position in shares of Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 651,702 shares of the company’s stock, valued at approximately $21,962,000. Norges Bank owned 1.36% of Avanos Medical as of its most recent filing […]
- 04/18/2020
|
Avanos Medical, Inc. Changes to Virtual Meeting Format for 2020 Annual Meeting of Stockholders
- Avanos Medical, Inc. (NYSE: AVNS) announced today that, due to the increasing public health risk posed by COVID-19 and in accordance with current governmental state of emergency orders, its 2020 Annual Meeting of Stockholders will be changed from an in-person meeting to a virtual meeting to be held solely by means of remote communication.
- 04/16/2020
|
Avanos Medical Inc (NYSE:AVNS) Shares Purchased by Geode Capital Management LLC
- Geode Capital Management LLC boosted its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 627,079 shares of the company’s stock after buying an additional 23,532 shares during the quarter. Geode […]
- 04/15/2020
|
Avanos Medical (NYSE:AVNS) Upgraded by Barclays to Equal Weight
- Avanos Medical (NYSE:AVNS) was upgraded by analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $30.00 target price on the stock. Barclays‘s price objective points to a potential upside of 3.63% from the company’s previous […]
- 04/13/2020
|
Leerink rolls out lineup of bullish calls in premarket analyst action
- Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1
- 04/13/2020
|
Did Changing Sentiment Drive Avanos Medical's (NYSE:AVNS) Share Price Down By 40%?
- This week we saw the Avanos Medical, Inc. (NYSE:AVNS) share price climb by 22%. But if you look at the last five years...
- 04/12/2020
|
Guggenheim Capital LLC Sells 14,020 Shares of Avanos Medical Inc (NYSE:AVNS)
- Guggenheim Capital LLC lessened its holdings in Avanos Medical Inc (NYSE:AVNS) by 64.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,783 shares of the company’s stock after selling 14,020 shares during the quarter. Guggenheim Capital LLC’s holdings in Avanos Medical were worth $262,000 […]
- 04/10/2020
|
Read This Before Selling Avanos Medical, Inc. (NYSE:AVNS) Shares
- We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
- 04/09/2020
|
Confluence Investment Management LLC Purchases 280,214 Shares of Avanos Medical Inc (NYSE:AVNS)
- Confluence Investment Management LLC raised its position in Avanos Medical Inc (NYSE:AVNS) by 86.0% in the 1st quarter, Holdings Channel reports. The firm owned 606,007 shares of the company’s stock after buying an additional 280,214 shares during the quarter. Confluence Investment Management LLC’s holdings in Avanos Medical were worth $16,320,000 at the end of the […]
- 04/09/2020
|
Bank of New York Mellon Corp Has $18.48 Million Position in Avanos Medical Inc (NYSE:AVNS)
- Bank of New York Mellon Corp lowered its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 2.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 548,384 shares of the company’s stock after selling 14,606 shares during the period. Bank […]
- 04/07/2020
|
Avanos Medical (NYSE:AVNS) Stock Price Up 8.3%
- Avanos Medical Inc (NYSE:AVNS) shares rose 8.3% during mid-day trading on Monday . The company traded as high as $26.22 and last traded at $25.74, approximately 387,360 shares changed hands during mid-day trading. A decline of 9% from the average daily volume of 425,062 shares. The stock had previously closed at $23.76. AVNS has been […]
- 04/07/2020
|
Here's Why You Should Hold on to Avanos Medical Stock Now
- Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.
- 04/06/2020
|
Here's Why You Should Hold on to Avanos Medical Stock Now
- Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.
- 04/06/2020
|
Mason Street Advisors LLC Increases Position in Avanos Medical Inc (NYSE:AVNS)
- Mason Street Advisors LLC boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,493 shares of the company’s stock after purchasing an additional 473 shares during the quarter. Mason Street Advisors LLC owned about 0.05% […]
- 04/05/2020
|
Cubist Systematic Strategies LLC Purchases 34,010 Shares of Avanos Medical Inc (NYSE:AVNS)
- Cubist Systematic Strategies LLC lifted its position in shares of Avanos Medical Inc (NYSE:AVNS) by 475.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,160 shares of the company’s stock after purchasing an additional 34,010 shares during the quarter. Cubist Systematic Strategies LLC […]
- 04/03/2020
|
Axa Boosts Holdings in Avanos Medical Inc (NYSE:AVNS)
- Axa grew its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 15.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 37,200 shares of the company’s stock after acquiring an additional 5,000 shares during the quarter. Axa owned 0.08% of Avanos Medical worth $1,254,000 […]
- 04/02/2020
|
Avanos Medical (NYSE:AVNS) Shares Down 12.8% After Analyst Downgrade
- Avanos Medical Inc (NYSE:AVNS) traded down 12.8% during trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $35.00 to $32.00. Stifel Nicolaus currently has a hold rating on the stock. Avanos Medical traded as low as $23.01 and last traded at $23.48, 500,702 shares traded hands during mid-day trading. An […]
- 04/02/2020
|
Stifel Nicolaus Reaffirms Their Hold Rating on Avanos Medical (AVNS)
- Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Avanos Medical (AVNS) today and set a price target of $32.00. The company's shares closed
- 04/01/2020
|
Amalgamated Bank Acquires 673 Shares of Avanos Medical Inc (NYSE:AVNS)
- Amalgamated Bank boosted its holdings in Avanos Medical Inc (NYSE:AVNS) by 9.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,935 shares of the company’s stock after acquiring an additional 673 shares during the quarter. Amalgamated Bank’s holdings in […]
- 04/01/2020
|
Avanos Medical (NYSE:AVNS) Given New $29.00 Price Target at Morgan Stanley
- Avanos Medical (NYSE:AVNS) had its target price lowered by Morgan Stanley from $32.00 to $29.00 in a report published on Friday morning, AnalystRatings.com reports. The brokerage currently has a sell rating on the stock. AVNS has been the topic of a number of other reports. ValuEngine raised shares of Avanos Medical from a hold rating […]
- 03/31/2020
|
Analysts Anticipate Avanos Medical Inc (NYSE:AVNS) Will Announce Earnings of $0.17 Per Share
- Equities analysts expect Avanos Medical Inc (NYSE:AVNS) to post earnings of $0.17 per share for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Avanos Medical’s earnings. The highest EPS estimate is $0.18 and the lowest is $0.15. Avanos Medical posted earnings per share of $0.15 in the same quarter […]
- 03/29/2020
|
Avanos Medical (AVNS) Gets a Sell Rating from Morgan Stanley
- In a report released today, David Lewis from Morgan Stanley maintained a Sell rating on Avanos Medical (AVNS), with a price target of $29.00. The
- 03/27/2020
|
Avanos Medical (AVNS) Gets a Sell Rating from Morgan Stanley
- In a report released today,
David Lewis
from Morgan Stanley maintained a
Sell
rating on Avanos Medical (
AVNS
–
Research Report
), with a price target of
$29.00
. The company’s shares closed last Monday at $25.58.
According to
TipRanks.com
, Lewis is
- 03/27/2020
|
Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 03/26/2020
|
Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?
- Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 03/26/2020
|
Blueshift Asset Management LLC Makes New $410,000 Investment in Avanos Medical Inc (NYSE:AVNS)
- Blueshift Asset Management LLC purchased a new position in shares of Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,175 shares of the company’s stock, valued at approximately $410,000. A number of other institutional investors and hedge funds […]
- 03/26/2020
|
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Bellerophon Therapeutics Inc (NASDAQ: BLPH) (follow-on rally from Friday's news of FDA authorization
- 03/24/2020
|
Avanos Medical Inc (NYSE:AVNS) Shares Purchased by Citigroup Inc.
- Citigroup Inc. increased its position in shares of Avanos Medical Inc (NYSE:AVNS) by 208.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,899 shares of the company’s stock after acquiring an additional 7,364 shares during the period. Citigroup Inc.’s […]
- 03/24/2020
|
Great West Life Assurance Co. Can Invests $779,000 in Avanos Medical Inc (NYSE:AVNS)
- Great West Life Assurance Co. Can acquired a new position in Avanos Medical Inc (NYSE:AVNS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 23,303 shares of the company’s stock, valued at approximately $779,000. Several other institutional investors have also […]
- 03/24/2020
|
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
- Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
- 03/24/2020
|
Avanos Medical Inc (NYSE:AVNS) Shares Acquired by Prudential Financial Inc.
- Prudential Financial Inc. grew its stake in Avanos Medical Inc (NYSE:AVNS) by 7.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,948 shares of the company’s stock after purchasing an additional 2,450 shares during the quarter. Prudential Financial Inc. owned approximately 0.07% […]
- 03/23/2020
|
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
- Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced commencement of international shipment of rapid COVID-19 test) * BioNTech SE - ADR (NASDAQ: BNTX) *
- 03/19/2020
|
Does Avanos Medical, Inc.’s (NYSE:AVNS) CEO Salary Reflect Performance?
- In 2017 Joe Woody was appointed CEO of Avanos Medical, Inc. (NYSE:AVNS). This report will, first, examine the CEO...
- 03/19/2020
|
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
- Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
- 03/19/2020
|
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Avanos Medical, Inc. for Potential Breach of Fiduciary Duty Claims
- NEW YORK, March 18, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Avanos Medical, Inc..
- 03/18/2020
|
Avanos Medical Inc (NYSE:AVNS) Short Interest Update
- Avanos Medical Inc (NYSE:AVNS) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,230,000 shares, a growth of 11.0% from the February 13th total of 2,910,000 shares. Approximately 6.8% of the shares of the company are short sold. Based on […]
- 03/16/2020
|
Avanos Medical (NYSE:AVNS) Trading Down 9.8%
- Avanos Medical Inc (NYSE:AVNS) was down 9.8% during mid-day trading on Wednesday . The stock traded as low as $28.62 and last traded at $29.01, approximately 589,213 shares were traded during mid-day trading. An increase of 52% from the average daily volume of 388,300 shares. The stock had previously closed at $32.17. Several analysts have […]
- 03/13/2020
|
The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings
- Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
- 03/13/2020
|
Edited Transcript of AVNS earnings conference call or presentation 25-Feb-20 2:00pm GMT
- Q4 2019 Avanos Medical Inc Earnings Call
- 03/10/2020
|
Avanos Medical Inc (NYSE:AVNS) Expected to Announce Earnings of $0.17 Per Share
- Brokerages forecast that Avanos Medical Inc (NYSE:AVNS) will report $0.17 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Avanos Medical’s earnings. The lowest EPS estimate is $0.15 and the highest is $0.18. Avanos Medical reported earnings of $0.15 per share during the same quarter last […]
- 03/08/2020
|
Contrasting Ocugen (NASDAQ:OCGN) & Avanos Medical (NASDAQ:AVNS)
- Ocugen (NASDAQ:OCGN) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Volatility and Risk Ocugen has a beta of 2.39, meaning that its stock price is 139% […]
- 03/08/2020
|
Avanos Medical Inc (NYSE:AVNS) Expected to Announce Quarterly Sales of $178.57 Million
- Analysts expect Avanos Medical Inc (NYSE:AVNS) to announce $178.57 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Avanos Medical’s earnings, with the highest sales estimate coming in at $179.70 million and the lowest estimate coming in at $177.80 million. Avanos Medical reported sales of […]
- 03/07/2020
|
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
- Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
- 03/04/2020
|
Barclays PLC Purchases 77,759 Shares of Avanos Medical Inc (NYSE:AVNS)
- Barclays PLC raised its position in Avanos Medical Inc (NYSE:AVNS) by 317.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 102,254 shares of the company’s stock after buying an additional 77,759 shares during the period. Barclays PLC owned about 0.21% of Avanos Medical worth $3,446,000 as […]
- 03/04/2020
|
Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
- Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
- 03/04/2020
|
Barclays Reiterates Sell Rating for Avanos Medical (NYSE:AVNS)
- Barclays reiterated their sell rating on shares of Avanos Medical (NYSE:AVNS) in a research note issued to investors on Thursday, AnalystRatings.com reports. Barclays currently has a $32.00 target price on the stock. Other equities research analysts also recently issued reports about the stock. ValuEngine upgraded shares of Avanos Medical from a hold rating to a […]
- 03/02/2020
|
Essex Investment Management Co. LLC Trims Position in Avanos Medical Inc (NYSE:AVNS)
- Essex Investment Management Co. LLC cut its stake in shares of Avanos Medical Inc (NYSE:AVNS) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,563 shares of the company’s stock after selling 702 shares during the period. Essex Investment Management […]
- 02/29/2020
|
Avanos Medical Inc Expected to Earn Q1 2020 Earnings of $0.15 Per Share (NYSE:AVNS)
- Avanos Medical Inc (NYSE:AVNS) – KeyCorp issued their Q1 2020 earnings estimates for Avanos Medical in a research report issued on Tuesday, February 25th. KeyCorp analyst M. Mishan forecasts that the company will post earnings of $0.15 per share for the quarter. Several other research firms have also commented on AVNS. Raymond James lowered Avanos […]
- 02/29/2020
|
2 Underperforming Stocks to Reduce
- They have fallen behind in recent years compared to the S&P; 500 index Continue reading...
- 02/28/2020
|
Avanos Medical Inc to Post Q2 2020 Earnings of $0.27 Per Share, KeyCorp Forecasts (NYSE:AVNS)
- Avanos Medical Inc (NYSE:AVNS) – Research analysts at KeyCorp issued their Q2 2020 EPS estimates for shares of Avanos Medical in a note issued to investors on Tuesday, February 25th. KeyCorp analyst M. Mishan anticipates that the company will post earnings of $0.27 per share for the quarter. KeyCorp also issued estimates for Avanos Medical’s […]
- 02/28/2020
|
Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4
- Avanos (AVNS) gains from segmental contributions in Q4.
- 02/27/2020
|
Avanos (AVNS) Earnings and Revenues Beat Estimates in Q4
- Avanos (AVNS) gains from segmental contributions in Q4.
- 02/27/2020
|
Analysts Conflicted on These Healthcare Names: Avanos Medical (AVNS) and Jazz Pharmaceuticals (JAZZ)
- Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Avanos Medical (AVNS) and Jazz Pharmaceuticals (JAZZ).
- 02/27/2020
|
Analysts Conflicted on These Healthcare Names: Avanos Medical (NYSE: AVNS) and Jazz Pharmaceuticals (NASDAQ: JAZZ)
- Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on Avanos Medical (
AVNS
–
Research Report
) and Jazz Pharmaceuticals (
JAZZ
–
Research Report
).
Avanos Medical (AVNS)
Barclays analyst
Kristen Stewart
mai
- 02/27/2020
|
Avanos Medical, Inc. Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
- Investors in Avanos Medical, Inc. (NYSE:AVNS) had a good week, as its shares rose 6.6% to close at US$32.84 following...
- 02/27/2020
|
Avanos Medical, Inc. Yearly Results: Here's What Analysts Are Forecasting For Next Year
- Investors in Avanos Medical, Inc. (NYSE:AVNS) had a good week, as its shares rose 6.6% to close at US$32.84 following...
- 02/27/2020
|
Avanos Medical Inc (NYSE:AVNS) Given Average Rating of "Hold" by Brokerages
- Shares of Avanos Medical Inc (NYSE:AVNS) have been assigned an average rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The […]
- 02/27/2020
|
Avanos Medical (NYSE:AVNS) Upgraded by ValuEngine to "Buy"
- Avanos Medical (NYSE:AVNS) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Tuesday, ValuEngine reports. Several other brokerages also recently issued reports on AVNS. Stifel Nicolaus downgraded shares of Avanos Medical from a “buy” rating to a “hold” rating and reduced their price […]
- 02/27/2020
|
Avanos Medical, Inc. (AVNS) Q4 2019 Earnings Call Transcript | The Motley Fool
- AVNS earnings call for the period ending December 31, 2019.
- 02/25/2020
|
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript
- Avanos Medical, Inc. (NYSE:AVNS) Q4 2019 Earnings Conference Call February 25, 2020 09:00 AM ET Company Participants Dave Crawford - Vice President of Investor
- 02/25/2020
|
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2020
|
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
- Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2020
|
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm ...
- 02/25/2020
|
Avanos Medical: 4Q Earnings Snapshot
- ALPHARETTA, Ga. (AP) _ Avanos Medical, Inc. (AVNS) on Tuesday reported a loss of $6.1 million in its fourth quarter.
The Alpharetta, Georgia-based company said it had a loss of 13 cents per share. Earnings, adjusted for one-time gains and costs, were
- 02/25/2020
|
Avanos Medical, Inc. to Host Earnings Call
- NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Avanos Medical, Inc. (NYSE:AVNS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at ...
- 02/25/2020
|
Investors Who Bought Avanos Medical (NYSE:AVNS) Shares A Year Ago Are Now Down 39%
- The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
- 02/25/2020
|
BRIEF-Avanos Medical Announces FDA Clearance Of 80-Watt Coolief Radiofrequency System For Neurological Lesion Procedures
- Avanos Medical Inc:
- 02/24/2020
|
Avanos Medical, Inc. Announces FDA Clearance of its New, 80-Watt COOLIEF* Radiofrequency System for Neurological Lesion Procedures
- Avanos Medical, Inc. (NYSE: AVNS) today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its new, 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion procedures. This easy-to-use system, comprised of a newly designed RF generator, peristaltic pump and therapy cables, enables physicians to perform a full spectrum of procedures including Cooled, Standard, Pulsed, TransDiscal and dual Bipolar RF.
- 02/24/2020
|
Avanos Medical, Inc. to Present at Two Investor Conferences in March
- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two investor conferences in March:
- 02/24/2020
|
Avanos Medical (AVNS) to Release Earnings on Tuesday
- Avanos Medical (NYSE:AVNS) is scheduled to be releasing its earnings data before the market opens on Tuesday, February 25th. Analysts expect Avanos Medical to post earnings of $0.32 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link. NYSE AVNS opened at $30.74 on […]
- 02/24/2020
|
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
- Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. Merck ...
- 02/23/2020
|
$177.83 Million in Sales Expected for Avanos Medical Inc (NYSE:AVNS) This Quarter
- Analysts predict that Avanos Medical Inc (NYSE:AVNS) will report $177.83 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Avanos Medical’s earnings, with the lowest sales estimate coming in at $175.00 million and the highest estimate coming in at $180.90 million. Avanos Medical reported sales of $169.90 […]
- 02/16/2020
|
Avanos Medical Inc (NYSE:AVNS) Expected to Post Earnings of $0.32 Per Share
- Brokerages expect Avanos Medical Inc (NYSE:AVNS) to post earnings per share of $0.32 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Avanos Medical’s earnings, with estimates ranging from $0.31 to $0.34. Avanos Medical reported earnings of $0.33 per share during the same quarter last year, which indicates […]
- 02/16/2020
|
Avanos Medical Inc (NYSE:AVNS) Shares Sold by North Star Asset Management Inc.
- North Star Asset Management Inc. reduced its position in Avanos Medical Inc (NYSE:AVNS) by 2.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 27,131 shares of the company’s stock after selling 664 shares during the period. North Star Asset Management Inc.’s holdings in Avanos Medical were worth $914,000 as of its most […]
- 02/14/2020
|
Avanos Medical, Inc. To Webcast Conference Call Discussing Fourth Quarter and Full-Year 2019 Financial Results
- ALPHARETTA, Ga., Feb. 11, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-year 2019 and its 2020 outlook on Tuesday, Feb. 25 at 9 a.m. ET. The company will issue a…
- 02/11/2020
|
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
- Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Biosciences ...
- 02/04/2020
|
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
- The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
- 02/04/2020
|
Contrasting Establishment Labs (NASDAQ:ESTA) & Avanos Medical (NASDAQ:AVNS)
- Avanos Medical (NYSE:AVNS) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Profitability This table compares Avanos Medical and Establishment Labs’ net margins, return on equity and […]
- 02/04/2020
|
Read This Before Selling Avanos Medical, Inc. (NYSE:AVNS) Shares
- It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- 02/01/2020
|
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ...
- 01/31/2020
|
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics ...
- 01/30/2020
|
Barclays Reiterates "Sell" Rating for Avanos Medical (NYSE:AVNS)
- Avanos Medical (NYSE:AVNS)‘s stock had its “sell” rating reissued by Barclays in a note issued to investors on Tuesday, AnalystRatings.com reports. They currently have a $30.00 price objective on the stock. Barclays‘s price target indicates a potential upside of 3.34% from the stock’s previous close. Several other equities analysts have also weighed in on AVNS. […]
- 01/30/2020
|
Barclays Reaffirms Their Sell Rating on Avanos Medical (AVNS)
- In a report released yesterday, Kristen Stewart from Barclays maintained a Sell rating on Avanos Medical (AVNS), with a price target of $30.00. The
- 01/28/2020
|
Barclays Reaffirms Their Sell Rating on Avanos Medical (AVNS)
- In a report released yesterday,
Kristen Stewart
from Barclays maintained a
Sell
rating on Avanos Medical (
AVNS
–
Research Report
), with a price target of
$30.00
. The company’s shares closed last Monday at $29.40, close to its 52-week low of $29.06
- 01/28/2020
|
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, ...
- 01/28/2020
|
The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
- Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (NASDAQ: ...
- 01/24/2020
|
What You Must Know About Avanos Medical, Inc.’s (NYSE:AVNS) Beta Value
- Anyone researching Avanos Medical, Inc. (NYSE:AVNS) might want to consider the historical volatility of the share...
- 01/20/2020
|
New Strong Sell Stocks for January 14th
- Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
- 01/14/2020
|
New Strong Sell Stocks for January 14th
- Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
- 01/14/2020
|
Diversified Trust Co Acquires 4,125 Shares of Avanos Medical Inc (NYSE:AVNS)
- Diversified Trust Co lifted its holdings in shares of Avanos Medical Inc (NYSE:AVNS) by 36.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 15,355 shares of the company’s stock after acquiring an additional 4,125 shares during the period. Diversified Trust Co’s holdings in Avanos Medical were worth […]
- 01/11/2020
|
